Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
Main Authors: | Tarryn Willmer, Rabia Johnson, Johan Louw, Carmen Pheiffer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00001/full |
Similar Items
-
Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
by: Tarryn Willmer, et al.
Published: (2018-12-01) -
Ethnic and Adipose Depot Specific Associations Between DNA Methylation and Metabolic Risk
by: Carmen Pheiffer, et al.
Published: (2020-09-01) -
The role of maternal DNA methylation in pregnancies complicated by gestational diabetes
by: Stephanie Dias, et al.
Published: (2022-09-01) -
Association of zinc level with DNA methylation and its consequences: A systematic review
by: Ziauddin Azimi, et al.
Published: (2022-10-01) -
Global and gene-specific DNA methylation in adult type 2 diabetic individuals: a protocol for a systematic review
by: Tinashe Mutize, et al.
Published: (2018-03-01)